The Zika virus: Lurking behind the COVID-19 pandemic?
Joseph V PergolizziJo Ann LeQuangSumiyo Umeda-RaffaCharles FleischerJoseph PergolizziClaudio PergolizziRobert B RaffaPublished in: Journal of clinical pharmacy and therapeutics (2020)
Until a vaccine is developed or effective treatment for Zika virus is discovered, healthcare providers must be AVP (aware, vigilant and proactive) in order to lessen the spread and impact of the implicated devastating birth defects (microcephaly) and other neurological disorders (eg Guillain-Barré Syndrome) of this infection. Unfortunately, many knowledge gaps exist. There is an urgent need for a reliable, inexpensive diagnostic test, an effective treatment and an approved and readily available vaccine.